DANA LAWSON: Open Payments
NPI 1235905365 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,834 in 80 payments from 28 companies in 2025. Trend: 2023 $128 · 2024 $3,299 · 2025 $2,834
Food & beverage: $2,756Education: $78
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 10 | $413 |
| AstraZeneca Pharmaceuticals LP | 9 | $327 |
| Regeneron Healthcare Solutions, Inc. | 5 | $301 |
| Novartis Pharmaceuticals Corporation | 10 | $253 |
| Janssen Biotech, Inc. | 5 | $229 |
| Janssen Scientific Affairs, LLC | 2 | $195 |
| Merck Sharp & Dohme LLC | 8 | $146 |
| SOBI, INC | 2 | $145 |
| Astellas Pharma US Inc | 2 | $138 |
| Pharmacosmos Therapeutics Inc. | 2 | $138 |
Products named: LIBTAYO, DATROWAY, RYBREVANT, Enhertu, Vonjo, Vyloy, Fabhalta, KEYTRUDA.
Industry payments across AZ — which companies pay providers there.
